Assay ID | Title | Year | Journal | Article |
AID88272 | Therapeutic index (vero CC50/ED50) against HSV-1 | 2003 | Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
| Anti-herpes simplex virus activity of substituted 1-hydroxyacridones. |
AID88268 | Inhibitory activity against HSV-1 in vero cells | 2003 | Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
| Anti-herpes simplex virus activity of substituted 1-hydroxyacridones. |
AID218235 | In vitro cytotoxic concentration in vero cells. | 2003 | Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
| Anti-herpes simplex virus activity of substituted 1-hydroxyacridones. |
AID88286 | Inhibitory activity against HSV-2 in vero cells | 2003 | Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
| Anti-herpes simplex virus activity of substituted 1-hydroxyacridones. |
AID88292 | Therapeutic index (vero CC50/ED50) against HSV-2; NA= not active | 2003 | Journal of medicinal chemistry, Nov-06, Volume: 46, Issue:23
| Anti-herpes simplex virus activity of substituted 1-hydroxyacridones. |
AID313340 | Antiviral activity against acyclovir-resistant HSV1 AR29 replication in Vero cells after 72 hrs | 2008 | Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
| SAR of a series of anti-HSV-1 acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3,4-h]-1,6-naphthyridine series. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |